{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "human ACE2", "isoflavonoids", "main protease", "molecular docking"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34068579", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "07"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "10"}], "Language": ["eng"], "ELocationID": ["2806", "10.3390/molecules26092806"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "9", "PubDate": {"Year": "2021", "Month": "May", "Day": "10"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M<sup>pro</sup>).", "Abstract": {"AbstractText": ["The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the \"COVID-19\" disease that has been declared by WHO as a global emergency. The pandemic, which emerged in China and widespread all over the world, has no specific treatment till now. The reported antiviral activities of isoflavonoids encouraged us to find out its in silico anti-SARS-CoV-2 activity. In this work, molecular docking studies were carried out to investigate the interaction of fifty-nine isoflavonoids against hACE2 and viral M<sup>pro</sup>. Several other in silico studies including physicochemical properties, ADMET and toxicity have been preceded. The results revealed that the examined isoflavonoids bound perfectly the hACE-2 with free binding energies ranging from -24.02 to -39.33 kcal mol<sup>-1</sup>, compared to the co-crystallized ligand (-21.39 kcal mol<sup>-1</sup>). Furthermore, such compounds bound the M<sup>pro</sup> with unique binding modes showing free binding energies ranging from -32.19 to -50.79 kcal mol<sup>-1</sup>, comparing to the co-crystallized ligand (binding energy = -62.84 kcal mol<sup>-1</sup>). Compounds <b>33</b> and <b>56</b> showed the most acceptable affinities against hACE2. Compounds <b>30</b> and <b>53</b> showed the best docking results against M<sup>pro</sup>. In silico ADMET studies suggest that most compounds possess drug-likeness properties."]}, "AuthorList": [{"Identifier": ["0000-0001-9202-1754"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Pharmaceutical Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Alesawy", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Pharmaceutical Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Abdallah", "ForeName": "Abdallah E", "Initials": "AE"}, {"Identifier": ["0000-0003-0630-709X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Pharmaceutical Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Taghour", "ForeName": "Mohammed S", "Initials": "MS"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Pharmaceutical Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "H Eissa", "ForeName": "Ibrahim", "Initials": "I"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Isoflavones"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zumla A., Chan J.F., Azhar E.I., Hui D.S., Yuen K.Y. Coronaviruses - drug discovery and therapeutic options. Nat. Rev. Drug Discov. 2016;15:327\u2013347. doi: 10.1038/nrd.2015.37.", "ArticleIdList": ["10.1038/nrd.2015.37", "PMC7097181", "26868298"]}, {"Citation": "Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24:490\u2013502. doi: 10.1016/j.tim.2016.03.003.", "ArticleIdList": ["10.1016/j.tim.2016.03.003", "PMC7125511", "27012512"]}, {"Citation": "WHO  WHO Coronavirus Disease (COVID-19) Dashboard.  [(accessed on 2 October 2020)]; Available online:  https://covid19.who.int/"}, {"Citation": "Dolin R., Hirsch M.S. Remdesivir\u2014An Important First Step. Massachusetts Medical Society; Waltham, MA, USA: 2020.", "ArticleIdList": ["PMC7269011", "32459913"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020;368:409\u2013412. doi: 10.1126/science.abb3405.", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Prajapat M., Sarma P., Shekhar N., Avti P., Sinha S., Kaur H., Kumar S., Bhattacharyya A., Kumar H., Bansal S. Drug targets for corona virus: A systematic review. Indian J. Pharmacol. 2020;52:56.", "ArticleIdList": ["PMC7074424", "32201449"]}, {"Citation": "Riordan J.F. Angiotensin-I-converting enzyme and its relatives. Genome Biol. 2003;4:1\u20135. doi: 10.1186/gb-2003-4-8-225.", "ArticleIdList": ["10.1186/gb-2003-4-8-225", "PMC193637", "12914653"]}, {"Citation": "Ichihara K.I., Fukubayashi Y. Preparation of fatty acid methyl esters for gas-liquid chromatography. J. Lipid Res. 2010;51:635\u2013640. doi: 10.1194/jlr.D001065.", "ArticleIdList": ["10.1194/jlr.D001065", "PMC2817593", "19759389"]}, {"Citation": "Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W. A novel coronavirus associated with severe acute respiratory syndrome. New Engl. J. Med. 2003;348:1953\u20131966. doi: 10.1056/NEJMoa030781.", "ArticleIdList": ["10.1056/NEJMoa030781", "12690092"]}, {"Citation": "Harmer D., Gilbert M., Borman R., Clark K.L. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. Febs Lett. 2002;532:107\u2013110. doi: 10.1016/S0014-5793(02)03640-2.", "ArticleIdList": ["10.1016/S0014-5793(02)03640-2", "12459472"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20131448. doi: 10.1126/science.abb2762.", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Tortorici M.A., Veesler D. Advances in Virus Research. Volume 105. Elsevier; Amsterdam, The Netherlands: 2019. Structural insights into coronavirus entry; pp. 93\u2013116.", "ArticleIdList": ["PMC7112261", "31522710"]}, {"Citation": "Yang J., Petitjean S.J., Koehler M., Zhang Q., Dumitru A.C., Chen W., Derclaye S., Vincent S.P., Soumillion P., Alsteens D. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat. Commun. 2020;11:1\u201310. doi: 10.1038/s41467-020-18319-6.", "ArticleIdList": ["10.1038/s41467-020-18319-6", "PMC7486399", "32917884"]}, {"Citation": "Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586\u2013590. doi: 10.1007/s00134-020-05985-9.", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Jia H.P., Look D.C., Shi L., Hickey M., Pewe L., Netland J., Farzan M., Wohlford-Lenane C., Perlman S., McCray P.B. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 2005;79:14614\u201314621. doi: 10.1128/JVI.79.23.14614-14621.2005.", "ArticleIdList": ["10.1128/JVI.79.23.14614-14621.2005", "PMC1287568", "16282461"]}, {"Citation": "Metwaly A.M., Lianlian Z., Luqi H., Deqiang D. Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules. 2019;24:1856. doi: 10.3390/molecules24101856.", "ArticleIdList": ["10.3390/molecules24101856", "PMC6572638", "31091790"]}, {"Citation": "Wang Y.-M., Ran X.-K., Riaz M., Yu M., Cai Q., Dou D.-Q., Metwaly A.M., Kang T.-G., Cai D.-C. Chemical Constituents of Stems and Leaves of Tagetespatula L. and Its Fingerprint. Molecules. 2019;24:3911. doi: 10.3390/molecules24213911.", "ArticleIdList": ["10.3390/molecules24213911", "PMC6864839", "31671631"]}, {"Citation": "Sperstad S.V., Haug T., Blencke H.-M., Styrvold O.B., Li C., Stensv\u00e5g K. Antimicrobial peptides from marine invertebrates: Challenges and perspectives in marine antimicrobial peptide discovery. Biotechnol. Adv. 2011;29:519\u2013530. doi: 10.1016/j.biotechadv.2011.05.021.", "ArticleIdList": ["10.1016/j.biotechadv.2011.05.021", "21683779"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (Covid-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Metwaly A.M., Wanas A.S., Radwan M.M., Ross S.A., ElSohly M.A. New \u03b1-Pyrone derivatives from the endophytic fungus Embellisia sp. Med. Chem. Res. 2017;26:1796\u20131800. doi: 10.1007/s00044-017-1889-7.", "ArticleIdList": ["10.1007/s00044-017-1889-7"]}, {"Citation": "Metwaly A., Kadry H., El-Hela A., Elsalam A., Ross S. New antimalarial benzopyran derivatives from the endophytic fungus Alternaria phragmospora. Planta Med. 2014;80:PC11. doi: 10.1055/s-0034-1382393.", "ArticleIdList": ["10.1055/s-0034-1382393", "PMC5047437", "27708462"]}, {"Citation": "Metwaly A. Comparative biological evaluation of four endophytic fungi isolated from nigella sativa seeds. Al-Azhar J. Pharm. Sci. 2019;59:123\u2013136. doi: 10.21608/ajps.2019.64111.", "ArticleIdList": ["10.21608/ajps.2019.64111"]}, {"Citation": "Yassin A.M., El-Deeb N.M., Metwaly A.M., El Fawal G.F., Radwan M.M., Hafez E.E. Induction of apoptosis in human cancer cells through extrinsic and intrinsic pathways by Balanites aegyptiaca furostanol saponins and saponin-coated silvernanoparticles. Appl. Biochem. Biotechnol. 2017;182:1675\u20131693. doi: 10.1007/s12010-017-2426-3.", "ArticleIdList": ["10.1007/s12010-017-2426-3", "28236195"]}, {"Citation": "Sharaf M.H., El-Sherbiny G.M., Moghannem S.A., Abdelmonem M., Elsehemy I.A., Metwaly A.M., Kalaba M.H. New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) Sci. Rep. 2021;11:1\u201316. doi: 10.1038/s41598-021-82550-4.", "ArticleIdList": ["10.1038/s41598-021-82550-4", "PMC7896049", "33608582"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Musa A. Two new antileishmanial diketopiperazine alkaloids from the endophytic fungus Trichosporum sp. Derpharmachemica. 2015;7:322\u2013327."}, {"Citation": "Metwaly A.M., Fronczek F.R., Ma G., Kadry H.A., Atef A., Mohammad A.-E.I., Cutler S.J., Ross S.A. Antileukemic \u03b1-pyrone derivatives from the endophytic fungus Alternaria phragmospora. Tetrahedron Lett. 2014;55:3478\u20133481. doi: 10.1016/j.tetlet.2014.04.085.", "ArticleIdList": ["10.1016/j.tetlet.2014.04.085", "PMC5047437", "27708462"]}, {"Citation": "Metwaly A.M., Kadry H.A., Atef A., Mohammad A.-E.I., Ma G., Cutler S.J., Ross S.A. Nigrosphaerin A a new isochromene derivative from the endophytic fungus Nigrospora sphaerica. Phytochem. Lett. 2014;7:1\u20135. doi: 10.1016/j.phytol.2013.09.001.", "ArticleIdList": ["10.1016/j.phytol.2013.09.001", "PMC5047436", "27708743"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In Vitro and In Silico Cytotoxic and Antibacterial Activities of a Diterpene from Cousinia alata Schrenk. J. Chem. 2021;2021 doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Ghoneim M.M., Afifi W.M., Ibrahim M., Elagawany M., Khayat M.T., Aboutaleb M.H., Metwaly A.M. Biological evaluation and molecular docking study of metabolites from Salvadora Persica L. Growing in Egypt. Pharmacogn. Mag. 2019;15:232."}, {"Citation": "Hegazy M.M., Metwaly A.M., Mostafa A.E., Radwan M.M., Mehany A.B.M., Ahmed E., Enany S., Magdeldin S., Afifi W.M., ElSohly M.A. Biological and chemical evaluation of some African plants belonging to Kalanchoe species: Antitrypanosomal, cytotoxic, antitopoisomerase I activities and chemical profiling using ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometer. Pharmacogn. Mag. 2021;17:6."}, {"Citation": "Orazbekov Y., Datkhayev U., Omyrzakov M., Metwaly A., Makhatov B., Jacob M., Ramazanova B., Sakipova Z., Azembayev A., Orazbekuly K. Antifungal prenylated isoflavonoids from Maclura aurantiaca. Planta Med. 2015;81:PE10. doi: 10.1055/s-0035-1556218.", "ArticleIdList": ["10.1055/s-0035-1556218"]}, {"Citation": "Dewick P.M. The Flavonoids: Advances in Research since 1980, Harborne, J.B., Ed. Springer US; Boston, MA, USA: 1988. Isoflavonoids; pp. 125\u2013209."}, {"Citation": "Arthan D., Svasti J., Kittakoop P., Pittayakhachonwut D., Tanticharoen M., Thebtaranonth Y. Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum. Phytochemistry. 2002;59:459\u2013463. doi: 10.1016/S0031-9422(01)00417-4.", "ArticleIdList": ["10.1016/S0031-9422(01)00417-4", "11830167"]}, {"Citation": "Okubo K., Kudou S., Uchida T., Yoshiki Y., Yoshikoshi M., Tonomura M. Food Phytochemicals for Cancer Prevention I. Volume 546. American Chemical Society; Washington, DC, USA: 1993. Soybean Saponin and Isoflavonoids; pp. 330\u2013339."}, {"Citation": "Horio Y., Sogabe R., Shichiri M., Ishida N., Morimoto R., Ohshima A., Isegawa Y. Induction of a 5-lipoxygenase product by daidzein is involved in the regulation of influenza virus replication. J. Clin. Biochem. Nutr. 2020;66:36\u201342. doi: 10.3164/jcbn.19-70.", "ArticleIdList": ["10.3164/jcbn.19-70", "PMC6983437", "32001954"]}, {"Citation": "Tait S., Salvati A.L., Desideri N., Fiore L. Antiviral activity of substituted homoisoflavonoids on enteroviruses. Antivir. Res. 2006;72:252\u2013255. doi: 10.1016/j.antiviral.2006.07.003.", "ArticleIdList": ["10.1016/j.antiviral.2006.07.003", "16934879"]}, {"Citation": "Desideri N., Olivieri S., Stein M., Sgro R., Orsi N., Conti C. Synthesis and anti-picornavirus activity of homo-isoflavonoids. Antivir. Chem. Chemother. 1997;8:545\u2013555. doi: 10.1177/095632029700800609.", "ArticleIdList": ["10.1177/095632029700800609"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "BIOVIA  . Discovery Studio Visualizer. BIOVIA; San Diego, CA, USA: 2012.  [(accessed on 22 March 2021)].  Available online:  https://discover.3ds.com/discovery-studio-visualizer-download."}, {"Citation": "Bank.  [(accessed on 2 January 2021)];2020  Available online:  https://www.rcsb.org/structure/6LZG."}, {"Citation": "Bank.  [(accessed on 2 January 2020)];2020  Available online:  https://www.rcsb.org/structure/6LU7."}, {"Citation": "Ibrahim M.K., Eissa I.H., Abdallah A.E., Metwaly A.M., Radwan M., ElSohly M. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists. Bioorganic Med. Chem. 2017;25:1496\u20131513. doi: 10.1016/j.bmc.2017.01.015.", "ArticleIdList": ["10.1016/j.bmc.2017.01.015", "28117121"]}, {"Citation": "El-Helby A.G.A., Ayyad R.R., Sakr H.M., Abdelrahim A.S., El-Adl K., Sherbiny F.S., Eissa I.H., Khalifa M.M. Design, synthesis, molecular modeling and biological evaluation of novel 2, 3-dihydrophthalazine-1, 4-dione derivatives as potential anticonvulsant agents. J. Mol. Struct. 2017;1130:333\u2013351. doi: 10.1016/j.molstruc.2016.10.052.", "ArticleIdList": ["10.1016/j.molstruc.2016.10.052"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Alesawy M.S., Metwaly A.M., Radwan M.M., ElSohly M.A. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists. Bioorganic Med. Chem. 2017;25:4723\u20134744. doi: 10.1016/j.bmc.2017.07.015.", "ArticleIdList": ["10.1016/j.bmc.2017.07.015", "28720328"]}, {"Citation": "Eissa I.H., Metwaly A.M., Belal A., Mehany A.B., Ayyad R.R., El-Adl K., Mahdy H.A., Taghour M.S., El-Gamal K.M., El-Sawah M.E. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Der Pharm. 2019;352:1900123. doi: 10.1002/ardp.201900123.", "ArticleIdList": ["10.1002/ardp.201900123", "31463953"]}, {"Citation": "PerkinElmer  . ChemBioDraw Ultra 14.0. PerkinElmer; Waltham, MA, USA: 2012.  [(accessed on 2 May 2015)].  Available online:  https://shopinformatics.perkinelmer.com/search."}, {"Citation": "El-Gamal K.M., El-Morsy A.M., Saad A.M., Eissa I.H., Alswah M. Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. J. Mol. Struct. 2018;1166:15\u201333. doi: 10.1016/j.molstruc.2018.04.010.", "ArticleIdList": ["10.1016/j.molstruc.2018.04.010"]}, {"Citation": "El-Zahabi M.A., Elbendary E.R., Bamanie F.H., Radwan M.F., Ghareib S.A., Eissa I.H. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists. Bioorganic Chem. 2019;91:103115. doi: 10.1016/j.bioorg.2019.103115.", "ArticleIdList": ["10.1016/j.bioorg.2019.103115", "31310882"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA  QSAR, ADMET and Predictive Toxicology.  [(accessed on 15 May 2020)]; Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Venkatapathy R., Wang N.C.Y., Martin T.M., Harten P.F., Young D. Structure\u2013Activity Relationships for Carcinogenic Potential. Gen. Appl. Syst. Toxicol. 2009 doi: 10.1002/9780470744307.gat079.", "ArticleIdList": ["10.1002/9780470744307.gat079"]}, {"Citation": "Goodrnan G., Wilson R. Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Anal. 1992;12:525\u2013533. doi: 10.1111/j.1539-6924.1992.tb00709.x.", "ArticleIdList": ["10.1111/j.1539-6924.1992.tb00709.x", "1480798"]}, {"Citation": "Council N.R. Issues in Risk Assessment. National Academies Press (US); Cambridge, MA, USA: 1993. Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment.", "ArticleIdList": ["8234946"]}, {"Citation": "Gonella Diaza R., Manganelli S., Esposito A., Roncaglioni A., Manganaro A., Benfenati E. Comparison of in silico tools for evaluating rat oral acute toxicity. Sar Qsar Environ. Res. 2015;26:1\u201327. doi: 10.1080/1062936X.2014.977819.", "ArticleIdList": ["10.1080/1062936X.2014.977819", "25567032"]}, {"Citation": "Pizzo F., Benfenati E. In Silico Methods for Predicting Drug Toxicity. Springer; Berlin/Heidelberg, Germany: 2016. In silico models for repeated-dose toxicity (RDT): Prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs; pp. 163\u2013176.", "ArticleIdList": ["27311467"]}, {"Citation": "Venkatapathy R., Moudgal C.J., Bruce R.M. Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. J. Chem. Inf. Comput. Sci. 2004;44:1623\u20131629. doi: 10.1021/ci049903s.", "ArticleIdList": ["10.1021/ci049903s", "15446819"]}, {"Citation": "Wilhelmus K.R. The Draize eye test. Surv. Ophthalmol. 2001;45:493\u2013515. doi: 10.1016/S0039-6257(01)00211-9.", "ArticleIdList": ["10.1016/S0039-6257(01)00211-9", "11425356"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "22"}, {"Year": "2021", "Month": "4", "Day": "10"}, {"Year": "2021", "Month": "4", "Day": "25"}, {"Year": "2021", "Month": "6", "Day": "2", "Hour": "1", "Minute": "22"}, {"Year": "2021", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["34068579", "PMC8126168", "10.3390/molecules26092806", "molecules26092806"]}}], "PubmedBookArticle": []}